Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats

Indian Journal of Experimental Biology

Volumn 42, Issue 8, 2004, Pages 766-769

  Anjaneyulu, Muragundla ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Cold allodynia; Diabetic neuropathy; Hot plate; Hyperalgesia; Quercetin; Tail immersion

Indexed keywords

ANTIOXIDANTS; ATTENUATION; DISEASES; GLUCOSE; LIVING SYSTEMS STUDIES; STRESS ANALYSIS;

DIABETIC NEUROPATHY; OXIDATIVE STRESSES; PLASMA GLUCOSE;

NEUROLOGY;

QUERCETIN;

ANIMAL; ARTICLE; COLD; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HEAT; HYPERALGESIA; MALE; PAIN; PAIN THRESHOLD; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; COLD; DIABETES MELLITUS, EXPERIMENTAL; HEAT; HYPERALGESIA; MALE; PAIN; PAIN THRESHOLD; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 4043146548     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. De Whalley C V, Rankin J F & Rankin S M, Flavonoids inhibit the oxidative modification of low-density lipoproteins, Bichem Pharmacol, 39 (1990) 1743.
2. Kaul T N, Middleton E & Jr Ogra P L, Antiviral effect of flavonoids on human viruses, J Med Virol, 15 (1985) 71.
3. Ramaswamy S, Padmanabha P, Gopalakhrishan V, Parmar N S & Gosh M N, Analgesic effect of O-(β-Hydroxy Ethyl) rutoside in mice, Indian J Exp Biol, 23 (1985) 219.
4. Viswanathan S, Sambantham P T, Kannappa R & Kameswaran L, Gossypin-induced analgesia in mice, Eur J Pharmacol, 98 (1984) 289.
5. Song B W, Tian W, Liu Y X, Chen Z W, Ma C G & Fang M, Studies on the analgesia of quercetin, J Anhui Med Uni, 29 (1994) 168.
6. Anjaneyulu M & Chopra K, Reversal of lipopolysaccharide-induced thermal and behavioural hyperalgesia by quercetin, Drug Dev Res, 58 (2003) 248.
7. Sanders R A, Rauscher F M & Watkins J B III. Effects of quercetin on antioxidant defence in streptozotocin-induced diabetic rats, J Biochem Mol Toxicol, 15 (2001) 143.
8. Murali B & Goyal R K, Effect of chronic treatment with losartan on streptozotocin induced diabetic nephropathy, Clin Exp Hypertens 23 (2001) 513.
9. Schmidt F H, Methoden der harn-und blutzuckerbestrim mung II: Handbuch Des, Diabetes Mellitus, 2 (1971) 938.
10. Anjaneyulu M & Ramarao P, Studies on gastrointestinal tract functional changes in diabetic animals, Methods Find Exp Clin Pharmacol, 2 (2002) 71.
11. Attal N, Jazat F, Kayser V & Guilbaud G, Further evidence for pain-related behaviours in a model of unilateral peripheral mononeuropathy, Pain, 41 (1990) 235.
12. Calcutt N A, Jorge M C, Yaksh T L & Chaplan S R. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: Effects of insulin, aldose reductase inhibition and lidocaine, Pain, 68 (1996) 293.
13. Ahlgreen S C & Levine J D. Mechanical hyperalgesia in streptozotocin-diabetic rats, Neuroscience, 52 (1993) 1049.
14. Ramabadran K, Bansinath M, Turndorf H & Puig M M, The hyperalgesic effect of naloxone is attenuated in STZ-diabetic mice, Psychopharmacology (Berl), 97 (1989) 169.
15. Kannan S A, Saade N E, Haddad J J, Abdelnoor A M, Atweh S F, Jabbur S J & Garabedian B S, Endotoxin-induced local inflammation and hyperalgesia in rats mince, a new model for inflammatory pain, Pharmacology, 66 (1996) 373.
16. Coopey L J, Gellett J S, Davidson E P, Dunlap J A, Lund D D & Yorec M A. Effect of antioxidant treatment of Streptozotocin-induced diabetic rats in endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve, Diabetes, 50 (2001) 1927.
17. Ueno Y, Kizaki M, Nakagiri R, Kamiya T, Sumi H & Osawa T. Dietary glutathione protects rats from diabetic nephropathy and neuropathy, J Nutr, 132 (2002) 897.
18. Cameron N E, Jack A K & Cotter M A. Effect of α-lipoic acid on vascular responses and nociception in diabetic rats, Free Radic Biol Medi, 31 (2001a) 125.
19. Cameron N E, Tuck Z, MeCabe L & Cotter M A, Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociceptive in experimental diabetes, Diabetologia, 44 (2001b) 1161.
20. Cheng L E & Breen K, On the ability of four flavonoids, baicilein, luteolin, naringenin and quercetin to suppress the fentone reaction of the iron-ATP complex, Biometals, 13 (2000) 77.
21. Da Silva El, Piskula M K, Yamamoto N, Moon J-H & Tero J, Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma, FEBS Lett, 430 (1998) 405.
22. Vinson J A & Bose P, Comparative bioavailability to humans of ascorbic acid alone or in a citrus extract, Am J Clin Nutr, 48 (1988) 601.
23. Salvi A, Carrupt P, Tillement J & Testa B, Structural damage to protein and influence of protein binding, Biochem Pharmacol, 61 (2001) 1237.
24. Zielinska M, Kostrzewa A & Lgnatowicz E, Antioxidative activity of flavonoids in stimulated human neutrophils, Folia Histochem Cytobiol, 38 (2000) 25.
25. Autore G, Rastrelli L, Lauro M R, Marzocco S, Sorrentino R & Sorrentino U. Inhibition of nitric oxide synthase expression by a methanolic extract of Crescentia alata and its derived flavonols, Life Sci, 70 (2001) 523.
26. A receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain, Eur J Pharmacol, 388 (2000) 29.
27. Ziegler D, Schatz H, Gries F A, Ulrich H & Reichel G, Effect of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study), Diabetes Care, 20 (1997) 369.
28. Chan E C, Pannangpeth P & Woodman O L, Relaxation to flavones and flavonols in rat isolated thoracic aorta: Mechanism action of action and structure activity relationship, J Cardiovasc Pharmacol, 35 (2000) 326